AKAP12/gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

Oncogene

Volumn 23, Issue 42, 2004, Pages 7095-7103

  Choi, Moon Chang ^a   Jong, Hyun Soon ^a   Kim, Tai Young ^a   Song, Sang Hyun ^a   Lee, Dong Soon ^a   Lee, Jung Weon ^a   Kim, Tae You ^a   Kim, Noe Kyeong ^a   Bang, Yung Jue ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

AKAP12; Alternative promoter; Apoptosis; DNA methylation; Histone deacetylation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; MEMBRANE PROTEIN; PROTEIN AKAP12; UNCLASSIFIED DRUG;

AKAP12 GENE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE SEQUENCE; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CARCINOMA; STOMACH TUMOR;

BASE SEQUENCE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MITOGENS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 4844227864     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207932     Document Type: Article

References (40)

1. Burgers WA, Fuks F and Kouzarides T. (2002). Trends Genet., 18, 275-277.
2. Cameron EE, Bachman KE, Myohanen S, Herman JG and Baylin SB. (1999). Nat. Genet., 21, 103-107.
3. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST and Vertino PM. (2000). Cancer Res., 60, 6236-6242.
4. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. (2000). Nat. Genet., 25, 315-319.
5. Dammann R, Takahashi T and Pfeifer GP. (2001). Oncogene, 20, 3563-3567.
6. Dell'Acqua ML and Scott JD. (1997). J. Biol. Chem., 272, 12881-12884.
7. Diviani D and Scott JD. (2001). J. Cell Sci., 114, 1431-1437.
8. Du Y, Carling T, Fang W, Piao Z, Sheu JC and Huang S. (2001). Cancer Res., 61, 8094-8099.
9. Esteller M. (2002). Oncogene, 21, 5427-5440.
10. Feliciello A, Gottesman ME and Avvedimento EV. (2001). J. Mol. Biol., 308, 99-114.
11. Gelman IH. (2002). Front. Biosci., 7, d1782-1797.
12. Gordon T, Grove B, Loftus JC, O'Toole T, McMillan R, Lindstrom J and Ginsberg MH. (1992). J. Clin. Invest., 90, 992-999.
13. Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA. (2001). Cancer Res., 61, 3573-3577.
14. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
15. Jones PA and Laird PW. (1999). Nat. Genet., 21, 163-167.
16. Jones PA and Taylor SM. (1980). Cell. 20, 85-93.
17. Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK and Bang YJ. (2002). Biochem. Biophys. Res. Commun., 292, 383-389.
18. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG. (2001). Cancer Res., 61, 2847-2851.
19. Kang SH, Bang YJ, Jong HS. Seo JY, Kim NK and Kim SJ. (1999). Br. J. Cancer, 80, 1144-1149.
20. Kim SG, Kim SN, Jong HS, Kim NK, Hong SH, Kim SJ and Bang YJ. (2001). Oncogene, 20, 1254-1265.
21. Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M and Bang YJ. (2003). Oncogene, 22, 3943-3951.
22. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ and Kim KW. (2003). Nat. Med, 9, 900-906.
23. Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE and Band V. (2001). Cancer Res., 61, 8014-8021.
24. Lin F, Wang H and Malbon CC. (2000a). J. Biol. Chem., 275, 19025-19034.
25. Lin X and Gelman IH. (1997). Cancer Res., 57, 2304-2312.
26. Lin X and Gelman IH. (2002). Biochem. Biophys. Res. Commun., 290, 1368-1375.
27. Lin X, Nelson P and Gelman IH. (2000b). Mol. Cell. Biol., 20, 7259-7272.
28. Lin X, Nelson PJ, Frankfort B, Tombler E, Johnson R and Gelman IH. (1995). Mol. Cell. Biol., 15, 2754-2762.
29. Liu L, Shao G, Steele-Perkins G and Huang S. (1997). J. Biol. Chem., 272, 2984-2991.
30. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J. (1991). Cancer Res., 51, 5449-5453.
31. Nauert JB, Klauck TM, Langeberg LK and Scott JD. (1997). Curr. Biol., 7, 52-62.
32. Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK and Bang YJ. (2003). Clin. Cancer res., 9, 433-440.
33. Sato N, Kokame K, Shimokado K, Kalo H and Miyata T. (1998). J. Biochem., 123, 1119-1126.
34. Shih M, Lin F, Scott JD, Wang HY and Malbon CC. (1999). J. Biol. Chem., 274, 1588-1595.
35. Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK and Bang YJ. (2001). Cancer Res., 61, 4628-4635.
36. Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, Kim WH and Bang YJ. (2000). Int. J. Cancer, 87, 236-240.
37. Tibiletti MG, Sessa F, Bernasconi B, Cerutti R, Broggi B, Furlan D, Acquati F, Bianchi M, Russo A, Capella C and Taramelli R. (2000). Clin. Cancer Res., 6, 1422-1431.
38. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD and Gazdar AF. (2001). Cancer Res., 61, 4556-4560.
39. Xia W, Unger P, Miller L, Nelson J and Gelman IH. (2001). Cancer Res., 61, 5644-5651.
40. Xiong Z and Laird PW. (1997). Nucleic Acids Res., 25, 2532-2534.